Albert Zlotnik

This inventor holds 44 USPTO granted patents and 11 published patent applications, plus 2 CIPO patents and 3 EPO patents, primarily in Chemosensory Receptors. Top assignees: Schering Corporation, Senomyx, Inc., Canji Inc.. Active years: 1997-2019.

USPTO Granted Patents = 44 (Patent Applications = 11)

% Patents Active = 63.6

CIPO Patents = 2 (Patent Applications = 3)

EPO Patents = 3 (Patent Applications = 11)

Average Co-Inventor Count = 4.8

ph-index = 9

Forward Citations = 515(Granted Patents)

Location History:

Palo Alto, CA (US) (1997 - 2013)
San Deigo, CA (US) (2014)
San Diego, CA (US) (2007 - 2019)

Company Filing History:

5. 1 out of 834,411

Other

patents

where one patent can have more than one assignee

Years Active: 1997-2019

Loading Chart...

Areas of Expertise:

Chemosensory Receptors

Taste Modulation

Chemokine Antibodies

CX3C Chemokines

Thymokine Lymphotactin

Sweet Taste Enhancement

Metastasis Inhibition

Nucleic Acids

Mammalian Cell Surface Antigens

Substituted Thienopyrimidine

CCL27 Polypeptides

Antibodies

44 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10191050 - Rationale, methods, and assays for identifying human and non-human primate taste specific genes and use thereof in taste modulator and therapeutic screening assays (2019-01-29),

2. 9739776 - Rationale, methods, and assays for identifying human and non-human primate taste specific genes and use thereof in taste modulator and therapeutic screening assays (2017-08-22),

3. 9603848 - Modulation of chemosensory receptors and ligands associated therewith (2017-03-28),

4. 9181276 - Modulation of chemosensory receptors and ligands associated therewith (2015-11-10),

5. 9139867 - Rationale, methods, and assays for identifying human and non-human primate taste specific genes and use thereof in taste modulator and therapeutic screening assays (2015-09-22),

6. 8669066 - Rationale, methods, and assays for identifying human and non-human primate taste specific genes and use thereof in taste modulator and therapeutic screening assays (2014-03-11),

7. 8633186 - Modulation of chemosensory receptors and ligands associated therewith (2014-01-21),

8. 8541421 - Methods of enhancing sweet taste of compositions using substituted thieno{2,3-D}pyrimidines (2013-09-24),

9. 8343492 - Method for blocking binding of CX3C chemokines using CX3C chemokine antibodies (2013-01-01),

10. 8173117 - Mouse CX3C chemokine polypeptides (2012-05-08),

11. 8119786 - Nucleic acids encoding CCL27 (2012-02-21),

12. 7932058 - Rationale, methods, and assays for identifying human and non-human primate taste specific genes and use thereof in taste modulator and therapeutic screening assays (2011-04-26),

13. 7928111 - Compounds including substituted thienopyrimidinone derivatives as ligands for modulating chemosensory receptors (2011-04-19),

14. 7785804 - [object Object] (2010-08-31),

15. 7601815 - Anti-CCL27 antibodies (2009-10-13),

Title: The Innovative Journey of Albert Zlotnik

Introduction: Albert Zlotnik, a prolific inventor based in San Diego, CA, has made significant contributions to the field of technology through his groundbreaking innovations.

Latest Patents: Albert Zlotnik holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his diverse range of expertise and creativity.

Career Highlights: With a career spanning over two decades, Albert Zlotnik has worked for various tech companies, leading research teams and spearheading projects that have resulted in cutting-edge inventions.

Collaborations: Throughout his career, Albert Zlotnik has collaborated with top researchers, engineers, and scientists from renowned institutions, fostering a culture of innovation and excellence in all his projects.

Conclusion: Albert Zlotnik's relentless pursuit of innovation and his passion for pushing the boundaries of technology make him a true visionary in the world of inventions.